About Vice-Principal ResearchNews
»Ê¹ÚÌåÓý’s alumnus-developed platform myLaminin brings high level of security to Research Data Management
Jul 15, 2025
»Ê¹ÚÌåÓý’s University Life Sciences graduate Ash Bassili’s company myLaminin is set to revolutionize how research data is managed, shared, and secured.
WE-CAN client Tammy Watson wins $10,000 at Equal Slice Pitch Competition
Jun 25, 2025
Tammy Watson, the Canadian Handywoman, is on a mission to empower women with tools, skills, and community.
Celebrating connection and community at the WE-CAN Mix + Mingle
Jun 16, 2025
On June 3, 2025, women entrepreneurs from across the Kingston area gathered for an in-person WE-CAN Mix + Mingle networking and community event.
QPI-supported Scale Up Platform startups took a deep dive into the differentiation process
Jun 05, 2025
Four of »Ê¹ÚÌåÓý’s Partnerships and Innovation (QPI)’s supported startups recently participated in a dynamic one-day workshop led by Andrew Jackson, the creator of the 5D Differentiationâ„¢ framework.
Dynamiris receives CABHI funding to further develop AI-enhanced eye tracking technology
May 27, 2025
Dynamiris Inc. is one of 23 funding recipients of the Centre for Aging + Brain Health Innovation’s (CABHI) Ignite program.
May 6, 2025: Canadian Patent No. 3,013,376 "Method and Apparatus for Acoustic and Tactile Presentation of Chemical Spectrum Data"
May 06, 2025
»Ê¹ÚÌåÓý's Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,013,376
May 6, 2025: Canadian Patent No. 3,022,981 "Hippo Pathway Bioluminescent Biosensor"
May 06, 2025
»Ê¹ÚÌåÓý's Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,022,981
April 29, 2025: U.S. Patent No. 12,286,558 "UV-Curable Anti-Smudge and Anti-Graffiti Compositions"
Apr 29, 2025
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,286,558
Glaucoma monitoring device receives CIHR commercialization funding
Apr 28, 2025
Contact lens-based device from »Ê¹ÚÌåÓý’s startup LenSense aims to transform glaucoma management and improve patient outcomes.
April 22, 2025: U.S. Patent No. 12,282,001 "Systems, Devices, and Methods for Electrochemical Water Analysis"
Apr 22, 2025
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,282,001
April 15, 2025: U.S. Patent No. 12,278,555 "Variable Gain Modulation Methods and Controllers for AC-DC Converter with Power Factor Correction"
Apr 15, 2025
»Ê¹ÚÌåÓý’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 12,278,555
Cntrl+ Inc. receives clearance from the US Food and Drug Administration
Apr 03, 2025
After an arduous journey, Cornwall-based Cntrl+ Inc. officially received clearance from the United States Food and Drug Administration (US FDA) for its reusable female bladder support in December 2024.